ZA200101689B - Nimesulide containing topical pharmaceutical compositions. - Google Patents
Nimesulide containing topical pharmaceutical compositions. Download PDFInfo
- Publication number
- ZA200101689B ZA200101689B ZA200101689A ZA200101689A ZA200101689B ZA 200101689 B ZA200101689 B ZA 200101689B ZA 200101689 A ZA200101689 A ZA 200101689A ZA 200101689 A ZA200101689 A ZA 200101689A ZA 200101689 B ZA200101689 B ZA 200101689B
- Authority
- ZA
- South Africa
- Prior art keywords
- composition
- weight
- nimesulide
- amount
- solution
- Prior art date
Links
- HYWYRSMBCFDLJT-UHFFFAOYSA-N nimesulide Chemical compound CS(=O)(=O)NC1=CC=C([N+]([O-])=O)C=C1OC1=CC=CC=C1 HYWYRSMBCFDLJT-UHFFFAOYSA-N 0.000 title claims description 56
- 229960000965 nimesulide Drugs 0.000 title claims description 56
- 239000012049 topical pharmaceutical composition Substances 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims description 70
- 239000000243 solution Substances 0.000 claims description 39
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 claims description 23
- -1 glyceryl monoolein Chemical compound 0.000 claims description 23
- 239000000499 gel Substances 0.000 claims description 22
- 229940074096 monoolein Drugs 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000003349 gelling agent Substances 0.000 claims description 13
- 239000003125 aqueous solvent Substances 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 8
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- 238000013019 agitation Methods 0.000 claims description 4
- 229960002504 capsaicin Drugs 0.000 claims description 4
- 235000017663 capsaicin Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000004973 liquid crystal related substance Substances 0.000 claims description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 2
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 claims description 2
- 241000723346 Cinnamomum camphora Species 0.000 claims description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000001293 FEMA 3089 Substances 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 229960000846 camphor Drugs 0.000 claims description 2
- 229930008380 camphor Natural products 0.000 claims description 2
- 239000001722 capsicum frutescens oleoresin Substances 0.000 claims description 2
- 229940050948 capsicum oleoresin Drugs 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 229940041616 menthol Drugs 0.000 claims description 2
- 150000002814 niacins Chemical class 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- 239000003352 sequestering agent Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 claims 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 claims 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 21
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 5
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 5
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006811 Bursitis Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 201000011275 Epicondylitis Diseases 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010073713 Musculoskeletal injury Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000000491 Tendinopathy Diseases 0.000 description 1
- 206010043255 Tendonitis Diseases 0.000 description 1
- 208000002240 Tennis Elbow Diseases 0.000 description 1
- 208000004760 Tenosynovitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008063 pharmaceutical solvent Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 201000004415 tendinitis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9817573A GB2340751B (en) | 1998-08-12 | 1998-08-12 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200101689B true ZA200101689B (en) | 2002-05-28 |
Family
ID=10837136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200101689A ZA200101689B (en) | 1998-08-12 | 2001-02-28 | Nimesulide containing topical pharmaceutical compositions. |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6818671B1 (xx) |
| EP (1) | EP1105114B1 (xx) |
| CN (1) | CN1227005C (xx) |
| AT (1) | ATE241348T1 (xx) |
| AU (1) | AU756007B2 (xx) |
| BR (1) | BR9914308A (xx) |
| CA (1) | CA2340224C (xx) |
| CZ (1) | CZ295601B6 (xx) |
| DE (1) | DE69908375T9 (xx) |
| DK (1) | DK1105114T3 (xx) |
| EA (1) | EA002694B1 (xx) |
| ES (1) | ES2200536T3 (xx) |
| GB (1) | GB2340751B (xx) |
| HU (1) | HU225044B1 (xx) |
| IL (1) | IL141365A0 (xx) |
| MX (1) | MXPA01001606A (xx) |
| NZ (1) | NZ510165A (xx) |
| PL (1) | PL202852B1 (xx) |
| PT (1) | PT1105114E (xx) |
| RS (1) | RS50116B (xx) |
| TR (1) | TR200100455T2 (xx) |
| WO (1) | WO2000009117A1 (xx) |
| ZA (1) | ZA200101689B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2406226A1 (en) * | 2000-04-18 | 2001-10-25 | Pharmacia Corporation | Rapid-onset formulation of a selective cyclooxigenase-2 |
| IN191090B (xx) * | 2000-08-29 | 2003-09-20 | Ranbanx Lab Ltd | |
| CA2448627A1 (en) * | 2001-05-31 | 2002-12-05 | Pharmacia Corporation | Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol |
| US7943166B2 (en) | 2003-04-10 | 2011-05-17 | Neurogesx, Inc. | Methods and compositions for administration of TRPV1 agonists |
| DK1613297T3 (da) * | 2003-04-14 | 2007-09-24 | Lohmann Therapie Syst Lts | Terapeutisk plaster med polysiloxanmatrix indeholdende capsaicin |
| US7618651B2 (en) | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
| US7854943B2 (en) | 2004-06-24 | 2010-12-21 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| US7858115B2 (en) | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| EP1865933B1 (en) * | 2005-03-30 | 2015-11-04 | Vanderbilt Royalty Sub L.P. | Low-concentration capsaicin patch and methods for treating neuropathic pain |
| CZ2005214A3 (cs) * | 2005-04-06 | 2006-10-11 | Zentiva, A. S. | Topická léková forma s obsahem nimesulidu |
| CN100346778C (zh) * | 2005-07-22 | 2007-11-07 | 海南康力元药业有限公司 | 尼美舒利缓释组合物 |
| US8017159B2 (en) | 2005-11-16 | 2011-09-13 | Idexx Laboratories, Inc. | Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| EP1902705A1 (en) * | 2006-09-22 | 2008-03-26 | Pharmatex Italia Srl | Injectable pharmaceutical nimesulide solutions |
| EP2498754B1 (en) | 2009-06-25 | 2018-06-06 | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. | Reverse hexagonal mesophases (h ii) and uses thereof |
| US8683770B2 (en) * | 2009-12-03 | 2014-04-01 | The Steel Network, Inc. | Connector assembly for connecting building members |
| USRE46844E1 (en) * | 2012-07-06 | 2018-05-15 | The Steel Network, Inc. | Connector assembly for connecting building members |
| RU2593777C1 (ru) * | 2015-04-20 | 2016-08-10 | Общество с ограниченной ответственностью "Трейдсервис" | Гелевая форма нимесулида, обладающая противовоспалительным и анальгетическим действием |
| WO2017027794A1 (en) | 2015-08-13 | 2017-02-16 | The Steel Network, Inc. | Connector systems, assemblies, and methods |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2982724A (en) * | 1956-05-08 | 1961-05-02 | Swift & Co | Hydraulic fluids for pressure treatment of oil bearing formation |
| US3840597A (en) * | 1971-02-24 | 1974-10-08 | Riker Laboratories Inc | Substituted 2-phenoxy alkane-sulfonanilides |
| GB9207988D0 (en) * | 1992-04-10 | 1992-05-27 | Smithkline Beecham Plc | Topical composition |
| DE69522696T2 (de) * | 1994-10-05 | 2002-04-18 | Helsinn Healthcare Sa | Nimesulid zur aüsserlichen anwendung |
| HUP9601442A3 (en) | 1995-07-25 | 1999-03-29 | Panacea Biotec Ltd | Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them |
| US5646151A (en) * | 1996-03-08 | 1997-07-08 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
| HUP9601443A3 (en) * | 1996-05-29 | 1999-03-29 | Panacea Biotec Ltd | Injectable analgetic pharmaceutical compositions for intramuscular use containing nimesulid, and process for producing them |
| IT1289972B1 (it) * | 1997-02-25 | 1998-10-19 | Helsinn Healthcare Sa | Formulazioni topiche di nimesulide in forma di sistemi a cristalli liquidi |
| IT1289973B1 (it) * | 1997-02-25 | 1998-10-19 | Helsinn Healthcare Sa | Sistemi gelificati di nimesulide per uso topico |
-
1998
- 1998-08-12 GB GB9817573A patent/GB2340751B/en not_active Revoked
-
1999
- 1999-08-12 HU HU0103202A patent/HU225044B1/hu not_active IP Right Cessation
- 1999-08-12 MX MXPA01001606A patent/MXPA01001606A/es active IP Right Grant
- 1999-08-12 CZ CZ2001543A patent/CZ295601B6/cs not_active IP Right Cessation
- 1999-08-12 RS YUP-114/01A patent/RS50116B/sr unknown
- 1999-08-12 EA EA200100226A patent/EA002694B1/ru not_active IP Right Cessation
- 1999-08-12 DE DE69908375T patent/DE69908375T9/de active Active
- 1999-08-12 CN CNB998119091A patent/CN1227005C/zh not_active Expired - Fee Related
- 1999-08-12 TR TR2001/00455T patent/TR200100455T2/xx unknown
- 1999-08-12 AT AT99936923T patent/ATE241348T1/de active
- 1999-08-12 IL IL14136598A patent/IL141365A0/xx not_active IP Right Cessation
- 1999-08-12 PT PT99936923T patent/PT1105114E/pt unknown
- 1999-08-12 AU AU51890/99A patent/AU756007B2/en not_active Ceased
- 1999-08-12 ES ES99936923T patent/ES2200536T3/es not_active Expired - Lifetime
- 1999-08-12 PL PL346019A patent/PL202852B1/pl not_active IP Right Cessation
- 1999-08-12 BR BR9914308-9A patent/BR9914308A/pt active Search and Examination
- 1999-08-12 WO PCT/IB1999/001460 patent/WO2000009117A1/en active IP Right Grant
- 1999-08-12 EP EP99936923A patent/EP1105114B1/en not_active Expired - Lifetime
- 1999-08-12 US US09/762,630 patent/US6818671B1/en not_active Expired - Fee Related
- 1999-08-12 CA CA002340224A patent/CA2340224C/en not_active Expired - Fee Related
- 1999-08-12 NZ NZ510165A patent/NZ510165A/en not_active IP Right Cessation
- 1999-08-12 DK DK99936923T patent/DK1105114T3/da active
-
2001
- 2001-02-28 ZA ZA200101689A patent/ZA200101689B/en unknown
-
2004
- 2004-08-25 US US10/925,663 patent/US7479508B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1105114B1 (en) | Nimesulide containing topical pharmaceutical compositions | |
| AU2008309170B2 (en) | A non-aqueous topical solution of diclofenac and process for preparing the same | |
| US5104656A (en) | Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent | |
| AU691583B2 (en) | Adhesive free topical pharmaceutical formulations | |
| EP0215423B1 (de) | Transdermal resorbierbare, wasserhaltige Zubereitungen von Arylpropionsäurederivaten und Verfahren zur Herstellung derselben | |
| CA2633515A1 (en) | Compositions and methods for dermally treating pain | |
| WO2001047559A9 (fr) | Pastilles a usage externe | |
| US20200301526A1 (en) | Novel non-aqueous topical solution of diclofenac and process for preparing the same | |
| JPS6061518A (ja) | ゲル状外用組成物 | |
| EP0175609B1 (fr) | Composition anesthésique percutanée pour usage topique et procédé d'application | |
| JPH05201879A (ja) | 経皮投与製剤 | |
| JPH0834731A (ja) | グラニセトロン含有経皮吸収型製剤 | |
| JP4653308B6 (ja) | ニメスリドを含む局所用医薬組成物 | |
| EP0372527B1 (en) | Topical compositions containing diclofenac | |
| KR100552650B1 (ko) | 피록시캄 함유 소염진통용 플라스터 | |
| Purohit et al. | Formulation and evaluation of diclofenac sodium organogel | |
| JPS59219218A (ja) | 局所用作用持続組成物 | |
| DE102021125624A1 (de) | Äußerlich anwendbare Zusammensetzung | |
| CN117396196A (zh) | 局部萘普生制剂及其用途 | |
| EP0417245A1 (en) | Topical analgesic composition |